Drawing from research on sepsis and complement biology, they developed the monoclonal antibody vilobelimab to block overactive inflammatory responses in patients with severe inflammatory diseases ...

Sepsis remains a leading cause of morbidity and mortality in critically ill patients, posing a major challenge to modern ...

Since Froedtert Hospital adopted the test, the mortality rate for sepsis patients has decreased by 42% and hospital length of ...

Patients are 20% less likely to die of sepsis because of a new AI system developed at Johns Hopkins University that catches symptoms hours earlier than traditional methods, an extensive hospital study ...